|
|
Article: Cephalon Announces Completion of Anticipated PROVIGIL Label Updates.
- Article from:
- PR Newswire
- Article date:
- September 17, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- PROVIGIL Label Revised; Now in Line with NUVIGIL Label Approved Last June -
FRAZER, Pa., Sept. 17 /PRNewswire-FirstCall/ -- Cephalon, Inc. today announced that it has finalized and shared with healthcare professionals revisions to the label for PROVIGIL(R) (modafinil) Tablets [C-IV], its wake-promoting agent. As announced by the company in both March and June of this year, these changes were necessary to make the PROVIGIL label consistent with the NUVIGIL(TM) (armodafinil) Tablets [C-IV] label approved and made available by the U.S. Food and Drug Administration (FDA) in June 2007. NUVIGIL is the single isomer formulation of modafinil, the active ingredient ...